Skip to main content
. 2020 Aug 17;24(18):10302–10310. doi: 10.1111/jcmm.15750

FIGURE 1.

FIGURE 1

The possible mechanism of m6A methylation in prostate cancer. miR‐493‐3p increased the m6A level and inhibited tumour carcinogenesis by down‐regulating its downstream target YTHDF2 in prostate cancer, and METTL3 inhibited the expression of LHPP and NKX3‐1 in an m6A‐YTHDF2‐dependent manner to further promote AKT phosphorylation‐induced tumour progression in prostate cancer